ArticleOncogene2018

Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer.

Özge Saatci et al.PubMed ↗Publisher ↗

No numbers read from the abstract.